GKOS
Price
$126.28
Change
+$0.01 (+0.01%)
Updated
Sep 13 closing price
45 days until earnings call
ICUI
Price
$179.00
Change
+$4.82 (+2.77%)
Updated
Sep 13 closing price
50 days until earnings call
Ad is loading...

GKOS vs ICUI

Header iconGKOS vs ICUI Comparison
Open Charts GKOS vs ICUIBanner chart's image
Glaukos
Price$126.28
Change+$0.01 (+0.01%)
Volume$339.9K
CapitalizationN/A
ICU Medical
Price$179.00
Change+$4.82 (+2.77%)
Volume$340.43K
CapitalizationN/A
View a ticker or compare two or three
GKOS vs ICUI Comparison Chart
Loading...
GKOS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ICUI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
GKOS vs. ICUI commentary
Sep 16, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GKOS is a StrongBuy and ICUI is a StrongBuy.

COMPARISON
Comparison
Sep 16, 2024
Stock price -- (GKOS: $126.28 vs. ICUI: $179.00)
Brand notoriety: GKOS and ICUI are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: GKOS: 62% vs. ICUI: 120%
Market capitalization -- GKOS: $4.61B vs. ICUI: $2.55B
GKOS [@Medical Specialties] is valued at $4.61B. ICUI’s [@Medical Specialties] market capitalization is $2.55B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GKOS’s FA Score shows that 1 FA rating(s) are green whileICUI’s FA Score has 1 green FA rating(s).

  • GKOS’s FA Score: 1 green, 4 red.
  • ICUI’s FA Score: 1 green, 4 red.
According to our system of comparison, both GKOS and ICUI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GKOS’s TA Score shows that 5 TA indicator(s) are bullish while ICUI’s TA Score has 4 bullish TA indicator(s).

  • GKOS’s TA Score: 5 bullish, 4 bearish.
  • ICUI’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, GKOS is a better buy in the short-term than ICUI.

Price Growth

GKOS (@Medical Specialties) experienced а -2.32% price change this week, while ICUI (@Medical Specialties) price change was +10.28% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +5.47%. For the same industry, the average monthly price growth was +6.61%, and the average quarterly price growth was -1.85%.

Reported Earning Dates

GKOS is expected to report earnings on Oct 30, 2024.

ICUI is expected to report earnings on Nov 04, 2024.

Industries' Descriptions

@Medical Specialties (+5.47% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GKOS($4.61B) has a higher market cap than ICUI($2.55B). ICUI YTD gains are higher at: 79.467 vs. GKOS (58.863). ICUI has higher annual earnings (EBITDA): 253M vs. GKOS (-82.12M). GKOS has more cash in the bank: 295M vs. ICUI (255M). GKOS has less debt than ICUI: GKOS (384M) vs ICUI (1.7B). ICUI has higher revenues than GKOS: ICUI (2.26B) vs GKOS (315M).
GKOSICUIGKOS / ICUI
Capitalization4.61B2.55B181%
EBITDA-82.12M253M-32%
Gain YTD58.86379.46774%
P/E RatioN/A333.33-
Revenue315M2.26B14%
Total Cash295M255M116%
Total Debt384M1.7B23%
FUNDAMENTALS RATINGS
GKOS vs ICUI: Fundamental Ratings
GKOS
ICUI
OUTLOOK RATING
1..100
8739
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
90
Overvalued
PROFIT vs RISK RATING
1..100
3188
SMR RATING
1..100
9592
PRICE GROWTH RATING
1..100
3936
P/E GROWTH RATING
1..100
712
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ICUI's Valuation (90) in the Medical Specialties industry is in the same range as GKOS (92). This means that ICUI’s stock grew similarly to GKOS’s over the last 12 months.

GKOS's Profit vs Risk Rating (31) in the Medical Specialties industry is somewhat better than the same rating for ICUI (88). This means that GKOS’s stock grew somewhat faster than ICUI’s over the last 12 months.

ICUI's SMR Rating (92) in the Medical Specialties industry is in the same range as GKOS (95). This means that ICUI’s stock grew similarly to GKOS’s over the last 12 months.

ICUI's Price Growth Rating (36) in the Medical Specialties industry is in the same range as GKOS (39). This means that ICUI’s stock grew similarly to GKOS’s over the last 12 months.

ICUI's P/E Growth Rating (2) in the Medical Specialties industry is significantly better than the same rating for GKOS (71). This means that ICUI’s stock grew significantly faster than GKOS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GKOSICUI
RSI
ODDS (%)
Bearish Trend 3 days ago
61%
Bearish Trend 3 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
65%
Momentum
ODDS (%)
Bearish Trend 3 days ago
75%
Bullish Trend 7 days ago
67%
MACD
ODDS (%)
Bearish Trend 3 days ago
69%
Bullish Trend 3 days ago
60%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
69%
Bullish Trend 3 days ago
67%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
65%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
67%
Declines
ODDS (%)
Bearish Trend 5 days ago
68%
Bearish Trend 12 days ago
67%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
78%
Aroon
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
63%
View a ticker or compare two or three
Ad is loading...
GKOS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ICUI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
QGIAX28.060.19
+0.68%
Pear Tree Quality Institutional
BRKUX13.980.07
+0.50%
MFS Blended Research Em Mkts Eq R4
ASMMX26.400.13
+0.49%
Invesco Summit A
FNCFX2.420.01
+0.41%
Franklin Income R6
EIVPX15.170.03
+0.20%
Parametric Volatil Risk Prm-Defensv I

GKOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GKOS has been loosely correlated with ICUI. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if GKOS jumps, then ICUI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GKOS
1D Price
Change %
GKOS100%
+0.01%
ICUI - GKOS
38%
Loosely correlated
+2.77%
PRCT - GKOS
36%
Loosely correlated
+0.90%
STAA - GKOS
33%
Loosely correlated
+8.04%
LMAT - GKOS
33%
Loosely correlated
+1.71%
KIDS - GKOS
33%
Poorly correlated
+2.15%
More

ICUI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICUI has been loosely correlated with TFX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ICUI jumps, then TFX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICUI
1D Price
Change %
ICUI100%
+2.77%
TFX - ICUI
46%
Loosely correlated
+1.37%
VCYT - ICUI
46%
Loosely correlated
+8.22%
XRAY - ICUI
43%
Loosely correlated
+3.51%
LMAT - ICUI
42%
Loosely correlated
+1.71%
AZTA - ICUI
42%
Loosely correlated
+3.41%
More